Home / Inspections / 1271673

FDA Inspection 1271673 — Sterling Pharma Ringaskiddy Limited

Sterling Pharma Ringaskiddy Limited — FEI 3002807776

The FDA completed an inspection of Sterling Pharma Ringaskiddy Limited on April 5, 2022 in Ringaskiddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 5, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ringaskiddy (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1123878 (VAI Fri Sep 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1004237 (NAI Fri Feb 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 881381 (NAI Fri Mar 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 694810 (NAI Wed Sep 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 548092 (NAI Wed Oct 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources